Theator
Theator is an AI-powered surgical decision support company.
Theator has raised €16M across 2 funding rounds from 2 investors, most recently a Series A round in Feb 2021. Based in Tel Aviv, Israel; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€16M
€15,560,040
Funding rounds
2
Investors
2
distinct backers
Active since
2019-04
latest 2021-02
Funding by year
EUR raised per yearTheator — funding by year — interactive chart.
Data table
| Theator — funding by year | |
|---|---|
| 2019 | €2.7M |
| 2021 | €13M |
Signals
High confidenceRaise-next likelihood10
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-02-09 | Series A | €13M | Insight Partners | View deal → |
| 2019-04-01 | Seed | €2.7M | StageOne Ventures | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData